Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 13/20 | 0.60 |
| ▸ | NPY1R | P25929 | 8/20 | 0.60 |
| ▸ | NPY2R | P49146 | 6/20 | 0.60 |
| ▸ | NPY5R | Q15761 | 6/20 | 0.60 |
| ▸ | IL23R | Q5VWK5 | 4/20 | 0.54 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.50 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15185880 | 0.90 | NPY4R (0.58) | NPY4RNPY1RNPY2RNPY5RIL23R | |
| SCHEMBL14479332 | 0.90 | GLP1R (0.53) | NPY4RNPY1RNPY2RNPY5RIL23R | |
| SCHEMBL16976111 | 0.88 | NPY4R (0.56) | NPY4RNPY1RNPY2RNPY5RIL23R | |
| SCHEMBL14479381 | 0.88 | GLP1R (0.54) | NPY4RNPY1RNPY2RNPY5RIL23R | |
| SCHEMBL10428706 | 0.87 | IL23R (0.54) | NPY4RNPY1RNPY2RNPY5RIL23R | |
| SCHEMBL10428709 | 0.87 | IL23R (0.54) | NPY4RNPY1RNPY2RNPY5RIL23R | |
| SCHEMBL14479322 | 0.87 | GLP1R (0.56) | NPY4RNPY1RNPY2RNPY5RIL23R | |
| SCHEMBL14479363 | 0.87 | GLP1R (0.56) | NPY4RNPY1RNPY2RNPY5RIL23R | |
| SCHEMBL14479382 | 0.87 | GLP1R (0.56) | NPY4RNPY1RNPY2RNPY5RIL23R | |
| SCHEMBL14479349 | 0.87 | GLP1R (0.56) | NPY4RNPY1RNPY2RNPY5RIL23R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9096646-B2 | CXCR4 receptor compounds | ANCHOR THERAPEUTICS, INC. (US) | 2015-08-04 | — | — | US | disclosed |